Search

everythinglearnresearchcommunity

for

Search:↓

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Urinary PSA could be an early marker for enlarged prostate.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Hair loss linked to prostate enlargement; stress and family history important factors.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Gene variation affects prostate issues and hair loss.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.